<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hereditary <z:mp ids='MP_0005638'>hemochromatosis</z:mp> (HH) is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> disorder characterized by enhanced intestinal absorption of dietary iron </plain></SENT>
<SENT sid="1" pm="."><plain>Without therapeutic intervention, <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> leads to multiple organ damage such as liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0001369'>arthritis</z:hpo>, <z:hpo ids='HP_0000135'>hypogonadism</z:hpo> and skin <z:hpo ids='HP_0001000'>pigmentation</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Most HH patients carry HFE mutant genotypes: homozygosity for p.Cys282Tyr or p.Cys282Tyr/p.His63Asp compound heterozygosity </plain></SENT>
<SENT sid="3" pm="."><plain>In addition to HFE gene, mutations in the genes that encode hemojuvelin (HJV), hepcidin (HAMP), transferrin receptor 2 (TFR2) and ferroportin (SLC40A1) have been associated with regulation of iron homeostasis and development of HH </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this review was to identify the main gene mutations involved in the pathogenesis of type 1, 2, 3 and 4 HH and their genetic testing indication </plain></SENT>
<SENT sid="5" pm="."><plain>HFE testing for the two main mutations (p.Cys282Tyr and p.His63Asp) should be performed in <z:hpo ids='HP_0000001'>all</z:hpo> patients with primary <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> and unexplained increased transferrin saturation and/or serum ferritin values </plain></SENT>
<SENT sid="6" pm="."><plain>The evaluation of the HJV p.Gly320Val mutation must be the molecular test of choice in suspected patients with juvenile <z:mp ids='MP_0005638'>hemochromatosis</z:mp> with less than 30 years and cardiac or <z:chebi fb="32" ids="24621">endocrine</z:chebi> manifestations </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, HH is an example that genetic testing can, in addition to performing the differential diagnostic with secondary <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e>, lead to more adequate and faster treatment </plain></SENT>
</text></document>